Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice
- 8 May 2001
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 1 (6) , 1211-1218
- https://doi.org/10.1016/s1567-5769(01)00058-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201Antimicrobial Agents and Chemotherapy, 2001
- Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus ActivitiesAntimicrobial Agents and Chemotherapy, 2001
- Antiviral activity of an immunomodulatory lipophilic desmuramyl dipeptide analogAntiviral Research, 1995
- Effect of Methionine Enkephalin on Natural Killer Cell and Cytotoxic T Lymphocyte Activity in Mice Infected with Influenza a VirusImmunopharmacology and Immunotoxicology, 1995
- Leukocyte Interleukin, INJ. (LI) Augmentation of Natural Killer Cells and Cytolytic T-LymphocytesImmunopharmacology and Immunotoxicology, 1995
- Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge.The Journal of Experimental Medicine, 1992
- The role of natural killer cells in human diseaseClinical Immunology and Immunopathology, 1989
- Severe Herpesvirus Infections in an Adolescent without Natural Killer CellsNew England Journal of Medicine, 1989
- Inhibition of Influenza Virus Replication in Tissue Culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): Mechanism of ActionJournal of General Virology, 1976
- MUCINS AND MUCOIDS IN RELATION TO INFLUENZA VIRUS ACTIONImmunology & Cell Biology, 1948